References
- Evans M. R., Preece A. Bristol. Med. Chir J 1973; 88: 17–20
- Kuttan G., Kuttan R. Immunological investigations 1992; 21: 285–296
- Kuttan G. Immunological investigations 1993; 22: 431–440
- Franz H. Pharmazie 1985; 40: 97–104
- Franz H. Oncology 1986; 43: 23–34
- Jordan E., Wagner H. Oncology 1986; 43: 8–15
- Antony S., Kuttan R., Kuttan G. J. Exp. Clin. Cancer Res 1997; 16: 159–162
- Immanuel Bergman, Roy Loxely. Clin. Chim. Acta 1970; 22: 347–349
- Skoza L., Mohos S. Biochem J 1976; 159: 457–462
- Suresh S. Tate, Alton Meister. J. Biol. Chem 1974; 22: 7593–7602
- Mazumder A., Rosenberg S. A. J. Exp. Med 1984; 159: 495–507
- Beuth J., Steur M. K., Lenartz D, Pulverer G. Z Alleg Med 1996; 72: 24–27
- Matthiessen P. F., Troger W. kombinerte tumour therapie, H. Wrba. Hippocrates verlag, Stuttgart 1990; 271–290
- Hajto T., Hostanska K., Freik K., Rordorf C., Gabius H. J. Cancer Res 1990; 50: 3322–3326
- Yogeswaran G. Adv Cancer Res 1983; 38: 289–350
- Passaniti A., Hart G. W. J. Biol. Chem 1988; 263: 7591–7603
- Rentae R., Lion E., Hunter R. Lab invest 1981; 44: 44–48
- Bloksma N., Van Dijk H, Krest P, Willers J. M. Immunobiology 1979; 156: 309
- Kazuhiko Okada, Uif Nannmark, Nikola L. Vujanovic, Simon Watkins, Per Basse, Ronald B. Herberma, Theresa L. Whiteside. Cancer Research 1996; 56: 1599–1608